Home » BREAST CANCER TREATMENT ABRAXANE APPROVED
BREAST CANCER TREATMENT ABRAXANE APPROVED
American Pharmaceutical Partners and American Bioscience have received approval for their breast cancer treatment, Abraxane.
Abraxane (paclitaxel protein-bound particles for injectable suspension) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within six months of adjuvant chemotherapy.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct